Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrocystic changes

J V Fiorica1

  • 1Department of Obstetrics and Gynecology, University of South Florida School of Medicine, Tampa.

Obstetrics and Gynecology Clinics of North America
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Fibrocystic breast changes are common. When atypical proliferative changes are present, breast cancer risk increases, necessitating biopsy for clear diagnosis and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of a chemoresponse assay in ovarian cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2014
Same author

Closure of WISDOM and combined HRT arm of WHI.

Climacteric : the journal of the International Menopause Society·2003
Same author

What is the role of interval blood testing in the management of chemotherapy for gynecologic malignancies.

European journal of gynaecological oncology·2003
Same author

Bartholin's gland carcinoma: a 15-year experience.

Gynecologic oncology·2001
Same author

Innovations in the management of vulvar carcinoma.

Current opinion in obstetrics & gynecology·2001
Same author

Surveillance of the endometrium in tamoxifen treated women.

Current opinion in obstetrics & gynecology·2001

Area of Science:

  • Reproductive medicine
  • Oncology
  • Pathology

Background:

  • Fibrocystic breast changes are highly prevalent among women.
  • Certain fibrocystic changes, particularly proliferative changes with atypia, are associated with elevated breast cancer risk.
  • Mastalgia (breast pain) management is a frequent clinical challenge in patients with fibrocystic breast conditions.

Purpose of the Study:

  • To highlight the diagnostic challenges in differentiating fibrocystic breast changes.
  • To emphasize the importance of accurate histologic evaluation for high-risk patients.
  • To underscore the clinical significance of managing mastalgia in the context of fibrocystic changes.

Main Methods:

  • Review of clinical presentations and diagnostic criteria for fibrocystic breast changes.

Related Experiment Videos

  • Discussion of the implications of proliferative changes with atypia.
  • Emphasis on the role of biopsy in clarifying ambiguous diagnoses.

    • Main Results:

    • Distinguishing between various types and variants of fibrocystic changes can be clinically challenging.
    • Histologic evaluation via biopsy is crucial when the diagnosis is uncertain.
    • Identifying patients with increased breast cancer risk due to specific fibrocystic changes is critical.

    Conclusions:

    • Accurate diagnosis of fibrocystic breast changes is essential for appropriate patient management.
    • Open surgical biopsy remains a key method for definitive histologic evaluation when needed.
    • Early and precise diagnosis can mitigate risks associated with atypical breast conditions.